Injective’s INJ heads toward Wall Street with proposed INJC staking ETF

Injective’s native token, INJ, may soon have a ticker that looks right at home in a standard brokerage account: INJC. Canary Capital is behind the proposed Staked INJ ETF. It submitted an amended registration statement to the SEC on September 24, 2026. The product would offer INJ exposure without a crypto wallet, and it plans to stake most of its holdings for extra yield. Injective is a Layer 1 blockchain built for finance and tokenization. It now finds itself in a growing pile of ETF paperwork, and its CEO thinks regulators may move faster than the market expects. What INJC actually is INJC would hold INJ tokens directly, giving investors spot exposure to the asset’s price. On top of that, the fund’s structure targets staking approximately 90% of its holdings. Staking means locking tokens up to help secure a blockchain network. In return, the network pays rewards. BitGo is set to serve as custodian, meaning it would hold the fund’s tokens. The fund is planned for listing on Cboe BZX. An S-1 is the registration document a company or fund files with the SEC before offering securities to the public. Amendments usually follow feedback or updates, so a revised filing suggests the proce...